4-(3-Fluorobenzyloxy)benzaldehyde, 95.0%, 25g

4-Ethynylpiperidin-4-ol hydrochloride, 95%, 5g

tert-butyl 4-(3-isopropyl-2,5-dioxopiperazin-1-yl)piperidine-1-carboxylate, 50mg

2-Methoxy-6-(methylsulfanyl)benzaldehyde, 95%, 10g

1-(2-chloro-5-nitrobenzoyl)-1,4-diazepane, 95.0%, 2g

(3-Methoxycyclohexyl)methanol, 98%, 500mg

3-Bromo-1H-pyrazolo[3,4-b]pyridin-5-amine, 95.0%, 250mg

2-Chloro-N-(cyclopropylmethyl)pyrimidin-4-amine, 95%, 2g

2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1), 98%, 100mg

N,N'-BIS(BENZYLOXYCARBONYL)GUANIDINE, 95.0%, 1g

(2E)-1-(3-bromophenyl)-3-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 10g

Hexane (isomers), min. 95% (isomers), for synthesis, 2.5 L, glass packaging

2,11-Dithia[3.3]paracyclophane>98.0%(HPLC)500mg